22-20992304-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM3
This summary comes from the ClinGen Evidence Repository: The NM_006767.4:c.1084C>T (p.Arg362Ter) variant in LZTR1 is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 10/21 and lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population filtering allele frequency in gnomAD v2.1 is 0.00003426 (15/251042 alleles) in the European (non-Finnish) population. Evidence supports that this variant is associated with AR NS and is not associated with AD NS. This variant has been detected in 1 individual with NS. That individual was compound heterozygous for the variant and another loss of function pathogenic variant confirmed in trans by parental testing (c.1149+1G>T) (PM3, PMID:31182298). Schwannomatosis has been observed in individuals harboring this variant (PMID:29384852). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: PM3, PVS1. (RASopathy VCEP specifications version 1.1; 9/17/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10118715/MONDO:0021060/094
Frequency
Consequence
NM_006767.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- LZTR1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- Noonan syndrome 10Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
- schwannomatosisInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Noonan syndromeInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- breast cancerInheritance: AD Classification: MODERATE Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006767.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LZTR1 | NM_006767.4 | MANE Select | c.1084C>T | p.Arg362* | stop_gained | Exon 10 of 21 | NP_006758.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LZTR1 | ENST00000646124.2 | MANE Select | c.1084C>T | p.Arg362* | stop_gained | Exon 10 of 21 | ENSP00000496779.1 | ||
| LZTR1 | ENST00000700578.1 | c.1084C>T | p.Arg362* | stop_gained | Exon 10 of 20 | ENSP00000515073.1 | |||
| LZTR1 | ENST00000461510.1 | TSL:2 | n.185C>T | non_coding_transcript_exon | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152170Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000598 AC: 15AN: 251042 AF XY: 0.0000663 show subpopulations
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461696Hom.: 0 Cov.: 36 AF XY: 0.0000743 AC XY: 54AN XY: 727176 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152288Hom.: 0 Cov.: 34 AF XY: 0.0000671 AC XY: 5AN XY: 74464 show subpopulations
Age Distribution
ClinVar
ClinVar submissions as Germline
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at